About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Home-Based Health Management of COPD Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02557178

Home-Based Health Management of COPD Patients

Minnesota HealthSolutions Corporation (MHS) proposes to develop and evaluate a program to motivate and monitor people with chronic obstructive pulmonary disease (COPD) to complete home exercise as par...

Lead sponsor: Sara Seifert•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sara Seifert

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)
Mayo Clinic

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•diagnosis of GOLD stage II, III, or IV COPD
•current or previous smoker with at least 10 pack-years of cigarette smoking
•be hospitalized for an exacerbation of COPD

Exclusion Criteria

•high likelihood of being lost to follow-up or contact
•inability to provide good data or follow commands
•inability to do mild exercise

Related studies

Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation

RECRUITINGPhase 2

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)

Innate Immunity in COPD

NCT05743582 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

NCT07190222 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 3

Non-invasive Ventilation or CPAP in OSA-COPD Following Admission for an Acute Hypercapnic Respiratory Failure

NCT07047092 · Chronic Obstructive Pulmonary Disease Exacerbation, Obstructive Sleep Apnea Exacerbation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment154

Start dateSep 2016

Last updatedFeb 24, 2021

Condition

Chronic Obstructive Pulmonary Disease

Locations shown

Mayo Clinic

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions